Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer. uri icon

authors

  • Nicole C. Schmitt, MD
  • Patel, Mihir R
  • Kaka, Azeem S
  • Gross, Jennifer H
  • Switchenko, Jeffrey
  • Steuer, Conor E
  • Shin, Dong M
  • Saba, Nabil F
  • Stokes, William A
  • Bates, James E
  • Kinney, Brendan L C
  • Remick, Jill
  • McDonald, Mark W
  • Rudra, Soumon
  • Steininger, Madison
  • Oyewole, Mosope

publication date

  • July 15, 2025